Related Experiment Video
Updated: Oct 1, 2026

Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response
Published on: September 15, 2017
[Stromelysin-1 in inflammatory disease: significance, specificity, and regulation elements]
1Université de Liège, Centre hospitalier universitaire du Sart-Tilman, Service de Rhumatologie, Centre d'Etude des Maladies inflammatoires chroniques.
Abstract:
Stromelysin-1 or matrix metalloproteinase-3 (MMP-3) is a key enzyme of the degradation of the extracellular matrix in rheumatoid arthritis. MMP-3 is indeed induced by pro-inflammatory cytokines and may in turn activate other metalloproteinases. MMP-3 is a synovial parameter reflecting the local inflammatory reaction induced by inflammatory cytokines. It is not specific for rheumatoid arthritis nor for the erosive capacity of an arthropathy, which does not exclude its role in articular degradation. Serum MMP-3 is increased in diseases characterized by synovitis but also by steroid therapy. Although it is not disease-specific, serum MMP-3 could be useful as a synovial-derived marker of local inflammation in rheumatoid arthritis, in parallel to CRP which is a systemic marker of inflammation. Furthermore, early determination of serum MMP-3 could constitute a new tool predictive of the disease activity and the therapeutic response in rheumatoid arthritis.
Insights
Matrix metalloproteinase-3 (MMP-3) is a key enzyme in rheumatoid arthritis joint degradation. Serum MMP-3 may serve as a valuable marker for predicting disease activity and treatment response.
Area of Science:
- Biochemistry
- Immunology
- Rheumatology
Context:
- Rheumatoid arthritis (RA) involves extracellular matrix degradation.
- Pro-inflammatory cytokines induce matrix metalloproteinase-3 (MMP-3).
- MMP-3 activates other metalloproteinases and reflects local inflammation.
Purpose:
- To evaluate the role of MMP-3 as a marker in rheumatoid arthritis.
- To assess MMP-3's potential in predicting disease activity and therapeutic response.
Summary:
- Stromelysin-1 (MMP-3) is crucial in RA extracellular matrix breakdown.
- Serum MMP-3 levels increase with synovitis and steroid therapy.
- While not specific to RA, MMP-3 is a useful synovial marker for local inflammation.
Impact:
- Serum MMP-3 can be a valuable tool for monitoring RA.
- Early MMP-3 determination may predict disease activity and treatment outcomes.
- MMP-3 offers a parallel marker to CRP for assessing inflammation in RA.
Related Concept Videos
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
The JAK-STAT Signaling Pathway
Acute Inflammation III: Local and Systemic Effects
Chronic Inflammation: Introduction
Determinants of Bacterial Pathogenicity and Virulence
Inflammatory Bowel Disease II: Ulcerative Colitis
